Antiviral sensitivity of Herpes simplex Virus in immunocompromised patients;Estudio de sensibilidad antiviral de Virus Herpes simplex en pacientes trasplantados

Revista Argentina de Microbiologia

Volumn 36, Issue 2, 2004, Pages 88-91

  Illan H ^a   Jacob, N ^b   Maiolo, E ^b   Cisterna, D ^a   Schiavelli, R ^b   Freire, M C ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

Author keywords

HSV; Inmunocompromised; Resistance

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; DNA POLYMERASE; FOSCARNET; MONOCLONAL ANTIBODY; NUCLEOSIDE ANALOG; PYROPHOSPHORIC ACID DERIVATIVE; THYMIDINE KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOPATHOGENIC EFFECT; DRUG SENSITIVITY; FEMALE; FIBROBLAST; GENE MUTATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IC 50; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; MALE; TRANSPLANTATION; VERO CELL; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN;

ACYCLOVIR; DRUG RESISTANCE, VIRAL; FOSCARNET; HERPES SIMPLEX; HUMANS; IMMUNOCOMPROMISED HOST; SIMPLEXVIRUS;

EID: 4444281417     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Andrei, G, Snoeck R, De Clercq E (1995) Susceptibilities of Several Drug-Resistant Herpes Simplex Virus Type 1 strains to alternative antiviral compounds. Antimicrob. Agets Chemother. 39: 1632-1635.
2. Christophers J, Clayton J (1998) Survey of resistence of herpes simplex virus to acyclovir in northwest England. Antimicrob. Agents Chemother 42: 868-872.
3. Collins P, Larder BA, Oliver M, Kemp S, Smith I, Darby G (1989) Characterization of a DNA polymerase mutant of herpes simplex virus from severely immunocompromised patient receiving acyclovir. J. Gen. Virol. 70: 375-382
4. Crumpacker CS, Schnipper LE, Marlowe P, Kowalsky PN, Hershey BJ, Levin MJ (1982) Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N. Engl. J. Med. 306: 343-346.
5. Ellis MN, Keller PM, Fyfe JA, Martin JL, Rooney JF, Strauss SE, et al. (1987) Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specifity. Antimicrob. Agents Chemother. 31: 1117-1125.
6. Whitley RJ (2001) Herpes Simplex viruses. In: Fields B, Knipe D, Howley PM (Ed) forth Edition, Chapter 73, Lippincott Williams & Wilkins.
7. Gimeno C (1996) Virus herpes simplex resistentes a drogas antivirales: incidencia y significación clínica en pacientes inmunocomprometidos (Tesis doctoral). Madrid: Facultad de Medicina, Universidad Complutense.
8. Hwang C, Ruffner KL, Coen DM (1992) A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance. J. Virol 66: 1774-1776.
9. Isenberg (1992) Antiviral Susceptibility Testing. Clinical Microbiology Procedures Handbook. American Society for Microbiology.
10. Nugier F, Collins P, Larder BA, Langlois M, Aymard M, Darby G (1991) Herpes simplex virus isolates from an immunocompromised patient who failed to respond to acuclovir treatment express thymidine kinase with altered substrate specifity. Antiviral Chem. Chemother. 2: 295-302.
11. Sacks SL, Wanklin RJ, Reece DE, Hicks KA, Tyler KL, Coen DM (1989) Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity. Ann. Intern. Med. 111: 893-899.
12. Safrin S, Assaykeen T, Follansbee S, Mills J (1990) Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J. Infect. Dis. 161: 1078-1084.
13. Safrin S, Elbeik T, Phan L, Robinson D, Rush J, Elbaggari A, et al. (1994) Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human inmunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 38: 1246-1250.
14. Sarisky R, Nguyen T, Duffy K, Wittrock R, Learny J (2000) Difference in incidence of spontaneous mutations between herpes simplex types 1 and 2. Antimicrob. Agents Chemother. 44: 1524-1529.
15. Suzutani T, Ishioka K, De Clerq E, Ishibashi K, Kaneko H, Kira T, et al. (2003) Differential Mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of Acyclovir or Penciclovir. Antimicrob. Agents Chemother. 44: 1707-1713.
16. Vinckier F, Boogaerts M, De Clercq D, De Clercq E (1987) Chronic herpetic infection in an inmunicompromised patient: report of a case. J. Oral Maxillofac. Surg. 45: 723-728.
17. Young Kyoo Shin, Guang-Yun Cal, Weinberg A, Learny J, Levin M (2000) Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. J. Clin. Microbiol. 39: 913-917.